The global orthopedic digit implants market is anticipated to witness substantial growth over the forecast period. The orthopedic digit implants are used for corrective surgery of damaged bones and joints. Key drivers for the orthopedic digit implants include a rise in the aging population, an increase in awareness regarding benefits of minimum invasive technology, and a growing occurrence of autoimmune disorder such as rheumatoid arthritis. According to statistics by WHO report 2019, rheumatoid arthritis prevalence is 1% in developed countries. Osteoarthritis is the most common type of arthritis that affects around 31 million Americans.
The orthopedic digit implants are segmented into metacarpal joint implants (upper extremity), metatarsal joint implants (lower extremity), Hemi phalangeal implants, scaphoid bone implants, toe intramedullary implants. The metatarsal joint implants (lower extremity) dominated the market and expected to grow over the forecast year. An increase in the occurrence of arthritis amongst the aging population is a key driver attributed to its dominance.
Based on material, the orthopedic digit implants are segmented into nitinol, silicon pyrocarbon, titanium, and others. Amongst this, titanium material segment held dominance as of 2018, due to higher biocompatibility and better corrosive resistance properties compared to other material.
Based on end-user, the orthopedic digit implant is segmented into hospital and specialty orthopedic clinics. Hospitals held dominance due to an increase in the footfall of patients due to improved quality and affordable healthcare. North America region is expected to dominate the orthopedic digit implants market due to a better healthcare facility efficient reimbursement process. Middle East Africa is anticipated to grow due to efforts by the government for improving healthcare quality.
The key players in the orthopedic digit implants market are Wright Medical Group N.V., Integra LifeSciences Corporation, TEIJIN NAKASHIMA MEDICAL CO., LTD., Stryker Corporation, DePuy Orthopaedics, Inc. (Johnson & Johnson), VILEX IN TENNESSEE, INC., and Merete Medical.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.